Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients.

Lee, Wen-Teng; Fang, Yu-Wei; Chen, Mingchih; Liou, Hung-Hsiang; Lee, Chung-Jen; Tsai, Ming-Hsien

Lee, Wen-Teng; Fang, Yu-Wei; Chen, Mingchih; Liou, Hung-Hsiang; Lee, Chung-Jen; Tsai, Ming-Hsien.

Afiliación

Lee WT; Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
Fang YW; Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
Chen M; Department of Medicine, Fu-Jen Catholic University School of Medicine, Taipei 242062, Taiwan.
Liou HH; Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City 242062, Taiwan.
Lee CJ; AI Development Center, Fu Jen Catholic University, New Taipei City 242062, Taiwan.
Tsai MH; Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City 242009, Taiwan.

J Clin Med ; 12(4)2023 Feb 16.

Article en En | MEDLINE | ID: mdl-36836085

Palabras clave

C-terminal fibroblast growth factor 23; bone mineral density; end-stage renal disease; hemodialysis; intact fibroblast growth factor 23

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google